Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
genentech
2
×
san francisco
acetylon pharmaceuticals
africa
ambys medicines
better ventures
biotech
boston blog main
boston top stories
california
cancer
cell therapy
chief operating officer
constellation pharmaceuticals
deals
diabetes
east africa
gene therapy
holger willenbring
illumina
ipo
jeffrey tong
juan carlos izpisua belmonte
keith dionne
lagos
life sciences
liver disease
markus grompe
martin burke
national blog main
national top stories
new york blog main
new york top stories
nigeria
oregon stem cell center
pharmaceutical
proteon therapeutics
roche
salk institute for biological studies
san diego blog main
What
new
treatments
2
×
advances
africa
aiming
ambys
apparent
available
big
biotech
century
change
comes
continent
control
deadly
deal
debuted
diseases
disregard
entire
formed
future
gene
genetic
genomic
hold
infrastructure
lack
launch
left
liver
make
manipulation
mapping
material
medical
medicines
pharmace
promise
Language
Current search:
genentech
×
treatments
×
@techcrunch.com
4 years ago
Only 2% of genomic material available for research comes from Africa, 54gene wants to change that
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?